Skip to main content Skip to megamenu

Whatʼs New

New Products for MSC Research

REPROCELL offers a variety of ready-to-ship products to support Mesenchymal Stem Cell (MSC) research, including iPSC-derived cell lines, media, and other culture reagents. Our cell lines are useful for differentiation and exosome production to promote a variety of disease models for research.

MSCs and related products

MSC - FCS graphs

Clinical MSC Production Service

Mesenchymal Stem Cells (MSCs) are involved in a variety of cell therapy and drug discovery programs. REPROCELL can help you drive your next clinical MSC project to success and ensure compliancy with regulatory agencies.

Clinical MSCs

Scientists in a clinical cell culture production lab
Human Tissue Pharmacology scientist in microscope lab

Human Tissue Pharmacology

Human fresh tissue testing bridges the gap between animal studies and clinical trials. We specialize in proof of concept studies in patient-derived living tissues, increasing your clinical success rates and adding commercial value to your preclinical drug assets.

Preclinical and drug discovery CRO

GMP scientist with TC flask and media pipette.jpg

Stem Cell Services for Cell Therapy Manufacturing

GMP iPSC and MSC Master Cell Banks and cells for your cell therapy project. Compliant with regulatory standards of the FDA, EMA, and PDMA.

Clinical stem cell services

CRISPR/Cas9 gene editing DNA

Alvetex® Bioengineered 3D Tissue Services

Complementing our fresh tissue assays by accurately recreating human biology in bioengineered tissues.

Bioengineered 3D tissue models

CRISPR/Cas9 gene editing DNA

StemEdit Clinical Gene Editing Service

Achieve the genotype you need using CRISPR-SNIPER, before moving on to expensive cell bank manufacturing processes.

Discover StemEdit

Bioserve India oligonucleotide boxes

Oligonucleotide Synthesis Services

Exceptional quality oligos, delivered worldwide. Custom synthesis, purification, and modification – all based on your requirements.

Oligonucleotide Synthesis

On the REPROCELL blog

Key Strategies Central Labs Use to Fast-Track Time to Market

Key Strategies Central Labs Use to Fast-Track Time to Market

Learn how central labs use automation, outsourcing, and AI to accelerate drug development, reduce costs, and improve clinical trial accuracy and efficiency.

18 November 2024

REPROCELL's Advanced Skin Tissue Engineering

REPROCELL's Advanced Skin Tissue Engineering

Discover REPROCELL's pioneering 3D skin tissue engineering, enhancing drug development and skincare research with accurate and robust human skin models.

31 October 2024

Plasma or Serum? – You Decide.

Plasma or Serum? – You Decide.

Discover the key differences between plasma and serum, their collection methods, and their impact on clinical and experimental outcomes.

17 October 2024

From Fibroblasts to Cancer-Attacking Cells: Insights from Recent Research on Natural Killer Cells Derived from Clinical Grade iPSCs

From Fibroblasts to Cancer-Attacking Cells: Insights from Recent Research on Natural Killer Cells Derived from Clinical Grade iPSCs

Discover the differentiation potential of induced pluripotent stem cells (iPSC) to cytotoxic NK cells, including recent advancements in research and therapy.

16 October 2024

The Power of Human Tissue Models in Preclinical Research

The Power of Human Tissue Models in Preclinical Research

Discover how human tissue models are transforming drug safety assessments and improving outcomes in preclinical research through real-world case studies.

03 October 2024

Upcoming Events

Conferences we will be attending, and webinars hosted by us

Events calendar


Webinar: Modeling cardiac pathologies with TrueCardium™

Find out more about establishing iPSC-derived self-organized cardiac organoids (all cell types of native human cardiac tissue) for drug discovery.

20 November 2024

Corporate News

More corporate news

PRESS RELEASE: New Study Highlights Role of Stromal Support in Bioengineered Human Intestinal Models

New study by Prof Stefan Przyborski at Durham University enhances drug testing models with stromal support in bioengineered human intestinal tissue.

13 November 2024

Press Release: Bioserve India Launches Advanced Stem Cell Products

Discover Bioserve India's advanced stem cell products, supporting innovation in research and drug development.

22 July 2024

REPROCELL USA Inaugurates GMP Manufacturing Facility for Stem Cells

REPROCELL USA unveils GMP manufacturing facility for hiPSC and hMSC, revolutionizing stem cell therapy with closed-system technology.

30 May 2024